Mass, volume, concentration, flow rates, clinical data like hemoglobin or creatinine — each with multiple possible units, each configurable per deployment. How do you ensure a value never loses its meaning, wherever and whenever it's read?

Comeo has been awarded the public tender from UKC Ljubljana (University Medical Centre Ljubljana) to deploy ComeoCare for the prescription, preparation and administration of cytostatic therapies. A first step into Slovenia, in partnership with Kiro Oncology (Grifols).

Here we go again! Comeo will be at the BOPP Days on January 23–24 in Blankenberge, where we’ll present the latest version of our solution and our newest innovations supporting safer and more efficient medication workflows. Come meet us and discover what’s new!

A quick look back at a year of product, regulatory and team milestones - and what’s ahead for Comeo.

💗 Early Sunday morning, our Comeo team joined the Think Pink – Race for the Cure in Brussels — running and walking together to support the fight against breast cancer. Proud to sponsor our team and contribute to Think Pink Belgium’s mission for awareness, research, and better care.

Issuing our yearly PSUR is always a chance to step back and reflect. This year, we’re proud to share that more than 900 patients are treated daily with the support of ComeoCare — helping healthcare teams calculate doses, compound medications, and administer treatments with greater safety.

We are pleased to announce the release of ComeoCare 4.3, introducing external compounding integration with systems including compounding robots, improved containers and manufacturing practices management for accurate handling of bags, pumps, syringes and diluents, and integrated reimbursement requests that streamline attestation workflows.

Comeo has been officially certified under the EU MDR regulation by BSI for its flagship solution, ComeoCare. This certification validates our commitment to the highest standards of safety, performance, and compliance in digital healthcare. With the MDR approval, Comeo is poised to expand beyond Belgium and Switzerland into new European markets.

Our partner BELIEVETec was recently recognized as Gold Sponsor of the Pan Arab Thalassemia & Sickle Cell Conference. These diseases require complex, protocol-based treatments — exactly what ComeoCare supports through smart, connected care across departments. Proud to empower better outcomes together.